Past Events

Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to gain more information about the advancement of their patent filings and to discuss their technology venture project with a one-on-one meeting with a Weill Cornell Business Development and Licensing Professional. The February 26th office hours will be hosted by Donna Rounds, Ph.D., Associate Director, Business Development and Licensing. 

Donna joined the startup world as one of the founders of Physiome Sciences, Inc., the first in-silico drug discovery platform using computational models of cells, tissues and organs. She later joined the British Technology Group (BTG Plc) as a technology scout, where she visited academic institutions across the East Coast searching for biotech projects in the early stages of development. Later, Donna joined Columbia Technology Ventures (CTV) and managed a portfolio of world-class scientists and Nobel laureates at Columbia University Vagelos College of Physicians and Surgeons. She was later recruited to lead the technology development program at Hospital for Special Surgery with a focus on musculoskeletal innovations and medical devices in orthopedics and rheumatology. Donna was on the scientific advisory board of Tohi Ventures and co-founded Nirova BioSense, which is dedicated to the development of optical sensors for real-time detection of ovarian cancer biomarkers.

Register here for your 30-minute private session.

Are you a STEM researcher interested in making an impact with your technology innovation? The National Science Foundation’s I-Corps program can provide you with professional training, mentoring and up to $50,000 in funding for customer discovery. 

Hosted by the Interior Northeast I-Corps Hub (IN I-Corps), the virtual NSF I-Corps Information Session on Wednesday, February 25 (12:00 – 12:45 p.m. ET) is designed for busy graduate students, postdocs and faculty interested in learning more about I-Corps regional and national programming. NSF I-Corps instructors and alumni will be in attendance to share their experience and answer questions. 

The NSF created I-Corps (Innovation Corps) to bridge the gap between fundamental research discoveries in science and engineering and the commercialization of technologies, products, and processes with the potential to benefit society.  

Register here. 

Over 10 weeks, Rev’s Prototyping Hardware Accelerator offers four tracks – Classic, AgTech, ClimateTech and MedTech - to guide product teams to determine if their ideas are commercially desirable, technologically feasible and economically viable. Upon completion of the program, participants are positioned to recruit team members, bring on partners, initiate work with contract manufacturers and pitch to investors. Teams will receive a stipend of up to $2,000 to advance their prototype. 

Register for an upcoming information session to have your questions answered by program leadership: 

• Thursday, February 19, 2026 from 5 – 6 PM ET 
• Tuesday, March 10, 2026 from 6 – 7 PM ET 

Ready to bring your product idea to life? – Apply Now. The final application deadline is midnight (ET) on March 22, 2026. Questions about the program can be directed to rev@revithaca.com.   

You are invited to attend a virtual info session for the Susan and Gene D. Resnick ’70, MD ’74 Prize for Excellence in Entrepreneurship (“Resnick Prize”). The Resnick Prize is an annual, university-wide competition that provides funding to startups with an active, intercampus collaboration. Startups initiated on the Weill Cornell (including Weill Cornell Medicine-Qatar), Cornell Ithaca, Cornell Tech campuses are eligible to apply as long as the startup has a license to Cornell-owned technology that touches Weill Cornell Medicine through either a research or clinical collaboration. We are seeking exciting collaborations where teams can work together on a technology that will be commercialized via a startup. The winning company will receive up to $10,000 in prize money.

The Resnick Prize seeks to fund projects in all sectors (therapeutics, devices, digital health, research & AI tools, etc) impacting healthcare and patient outcomes. Teams must have incorporated their company to be eligible for the award.  

RSVP here.